Delivery Order SPE2DB22D2218-SPE2DB25FR2GX
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$6.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $15,064.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of the prescription medication Rexulti 1 mg tablet, with an ultimate completion date of May 6, 2025. The contract is not set aside and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $19,290.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply 4,568,062,178 units of the prescription medication Rexulti 2 mg tablet. The contract has a firm fixed price and an ultimate completion date of April 29, 2025. This order is not set aside and appears to be part of a larger Indefinite Delivery...
This federal contract award, valued at $16,730.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Rexulti 0.5 mg tablet, with an ultimate completion date of April 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $9,219.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for a delivery order of the prescription medication Rexulti 1 mg tablet, with an ultimate completion date of April 23, 2025. This contract is not designated as a set-aside and is a firm fixed-price contract. Additionally, AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award, valued at $4,989.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the medical product Rexulti 1 mg Tablet 30s, a prescription medication. The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, identified as SPE2DB22D3004|SPE2DB25FQH08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,188.39 fixed-price delivery order is for the supply of the pharmaceutical product Rexulti 1 mg tablets. The contract is not set aside and represents an order under AmerisourceBergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC), designated as SPE2DX, with the DLA Troop Support Medical....
This federal contract award, valued at $27,845.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the prescription drug Rexulti 1 mg tablets. The contract is a firm fixed-price Delivery Order (DO) with a period of performance through September 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,769.27 fixed-price contract is for the delivery of the prescription medication Rexulti 1 mg tablet, with a performance period through April 2025. The award is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $13,179.66 firm-fixed-price delivery order is for the supply of Rexulti 1 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,108.73 firm fixed-price delivery order contract is for the supply of Rexulti 1 mg tablets. The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...